Skip to main content
Home

Breadcrumb

  1. Home
  2. Knowledge Intensive Services

Knowledge Intensive Services

Analytics for clinical development strategy: Integrated optimization of an oncology program
15 November 2024

Analytics for clinical development strategy: Integrated optimization of an oncology program

Achieving a return on invested capital (ROIC) that exceeds the cost of capital remains a challenge for pharmaceutical R&D. To make progress, there needs to be consistent and rigorous modeling of the clinical and commercial determinants of ROIC. In the second of three articles, CRA’...

CMS’ Alzheimer’s NCD: Outlier or harbinger of increased scrutiny?
15 November 2024

CMS’ Alzheimer’s NCD: Outlier or harbinger of increased scrutiny?

Aduhelm was the first FDA-approved disease-modifying treatment for Alzheimer’s, sparking debate among providers, regulators, and patients. Aduhelm received a controversial accelerated approval from the FDA in June 2021, a decision that balanced the lack of consensuses among the scientif...

Analytics for clinical development strategy: A unified approach to optimizing return on investment in R&D
5 November 2024

Analytics for clinical development strategy: A unified approach to optimizing return on investment in R&D

Despite the rapid scientific advances with new targets, modalities, and biomarkers, the return on invested capital (ROIC) in novel therapeutics remains low. The problem stems from the large investment needed, high risks of failure, and long timelines until revenues can be realized. This...

Infertility - A public health concern
4 November 2024

Infertility - A public health concern

The World Health Organization (WHO) estimates that one out of six people globally are impacted by the inability to conceive a child. Over the last decade, countries around the world have seen a decline in total fertility rates, most notably in economically developed countries withi...

chris-dunn
20 November 2024

Chris Dunn shortlisted as a Top UK Business Adviser

Chris Dunn has been shortlisted for the UK’s Top Business Advisers Awards. Chris who delivers consulting, coaching, and mentoring services to help entrepreneurs grow their business was picked from hundreds of advisers from around the UK for his outstanding work in business development. ...

The EpiCentre, Haverhill
20 November 2024

The EpiCentre is working with Microsoft to support innovative early-stage businesses

Oxford Innovation Space that manages The EpiCentre at Haverhill and Microsoft have announced that they are working together to support the growth of innovative early-stage businesses. ...

chris-dunn-coaching-website
15 November 2024

Chris Dunn Coaching goes live

Welcome to the Chris Dunn Coaching website - the home of impact and performance for leaders and aspiring leaders. ...

simple graphic emblematic of migrating an IT environment from Google Workspace to Microsoft 365 using ShareGate
14 November 2024

New Google to Microsoft 365 migration product by ShareGate

ShareGate has produced a new tool that should make it easier to undertake Google Workspace to Microsoft 365 migrations. ...

Keytruda LoE: A seismic shift for oncology?
14 November 2024

Keytruda LoE: A seismic shift for oncology?

Immune checkpoint inhibitors (ICIs) have changed the face of oncology treatment since their initial entry in the early 2010s. Driven mostly by the group of PD-1 and PD-L1 molecules, they have resulted in cumulative 2023 global revenues exceeding $45 billion USD. Within the PD-...

Gary Jennings, Innovation Director, The EpiCentre
11 November 2024

The Epicentre launches a new growth accelerator programme to help its occupiers build for their future

The Epicentre at Haverhill has launched a growth accelerator programme to help its clients’ growth with two unique options to suit startups, R&D spinouts, and established SMEs ...

Pagination

  • First page «
  • Previous page ‹‹
  • …
  • Page 43
  • Page 44
  • Current page 45
  • Page 46
  • Page 47
  • …
  • Next page ››
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS